Grammar:		DataElement 4.1
Namespace:		shr.oncology
Description:	"SHR implementation of ASCO requirements."
Uses:  			shr.core, shr.base, shr.problem, shr.lab, shr.observation

CodeSystem:     SCT = http://snomed.info/sct
CodeSystem:     LNC = http://loinc.org
CodeSystem:		MTH = http://ncimeta.nci.nih.gov
CodeSystem:     UCUM = http://unitsofmeasure.org

EntryElement:	BreastCancerStage
Concept:		LNC#21908-9
Based on:		CodeableConceptObservation
Description:	"The stage of breast cancer, assessed according to the standard established by American Joint Committee on Cancer (AJCC). TNM Stage Grouping which categorizes the progression of cancer using the Roman Numeral system. See Table 140 in HL7 CDA速 R2 Implementation Guide: Clinical Oncology Treatment Plan and Summary, Release 1 - US Realm"
Value:			CodeableConcept from urn:oid:2.16.840.1.113883.11.20.11.12 
				ObservationCode is LNC#21908-9
1..1			BreastTumorCategory    // component
1..1			BreastNodeCategory 
1..1			BreastMetastatisCategory
0..1			PostSurgeryIndicator    // qualifier

	EntryElement:	BreastTumorCategory	
	Concept:		LNC#59528-0 
	Based on:		CodeableConceptObservation
	Description:	"The TNM tumor category based on the tumor size (greatest dimension), based on criteria from the American Joint Committee on Cancer. See Table 152 in HL7 CDA速 R2 Implementation Guide: Clinical Oncology Treatment Plan and Summary, Release 1 - US Realm"
	Value:			CodeableConcept from urn:oid:2.16.840.1.113883.11.20.11.13 
					ObservationCode is LNC#59528-0
	
	EntryElement:	BreastNodeCategory	
	Concept:		LNC#59525-6
	Based on:		CodeableConceptObservation
	Description:	"The presence of metastases in regional lymph nodes. TNM node category for staging derived from the American Joint Committee on Cancer. See Table 147 in HL7 CDA速 R2 Implementation Guide: Clinical Oncology Treatment Plan and Summary, Release 1 - US Realm"
	Value:			CodeableConcept from urn:oid:2.16.840.1.113883.11.20.11.14
					ObservationCode is LNC#59525-6
	
	Element:		BreastMetastatisCategory
	Concept:		LNC#59522-3
	Based on:		CodeableConceptObservation
	Description:	"Part of the TNM classification system representing metastases.  The system is used to describe the spread of cancer to other parts of the body. See Table 144 in HL7 CDA速 R2 Implementation Guide: Clinical Oncology Treatment Plan and Summary, Release 1 - US Realm"
	Value:			CodeableConcept from urn:oid:2.16.840.1.113883.11.20.11.25 
					ObservationCode is LNC#59522-3
	
	Element:		PostSurgeryIndicator
	Concept:		TBD
	Description:	"Indicator, when true, indicates the stage is reflects the tumor size extent and location after surgical removal. If missing, it is assumed the staging is not post-surgical."
	Value:			boolean

	
EntryElement:	MetastaticBreastCancerDiagnosis 
Concept:		MTH#C1446377
Based on:		Problem
Description:	"A diagnosis of Stage IV breast cancer, cancer originating in the breast that has spread to other organs of the body, most often the bones, lungs, liver, or brain."
Value:			CodeableConcept from MetastaticBreastCancerDiagnosisVS
				ProblemCategory includes #disease
1..1			GradeOrStage is SCT#2640006 "Clinical stage IV"
1..1			BodySite is type PrimaryTumorBodySite
0..0			NonOccurrenceModifier
				IncludeOnProblemList is true
				
			Element: 		PrimaryTumorBodySite
			Based on:		BodySite
			Concept:		TBD
			Description:	"The body site of the primary tumor."
			
Element:		ReceptorStatusObservation   // abstract parent class. Do we need a new keyword?
Concept:		MTH#C0449443
Based on:		CodeableConceptObservation
Description:	"Refers to the presence or absence of specific receptor molecules on the surface of a cells in a specimen."
Value:			CodeableConcept from PositiveNegativeVS
1..1			Receptor
0..1			ReceptorPositivityPercentage
0..1			ReceptorProportionScore
0..1			ReceptorIntensityScore
0..1			ReceptorTotalScore

		Element:		Receptor
		Concept:		MTH#C0597357 //or SCT#116647005
		Description:	"A protein located on the cell surface, or in the cytoplasm, that binds to a specific signaling factor, such as a hormone, antigen, or neurotransmitter, causing a conformational and functional change in the receptor molecule. The ligand-bound receptor then alters its interaction with target molecules, which leads to changes in cellular physiology through modification of the activity of one or more signal transduction pathways."
		Value:			CodeableConcept from ReceptorVS

		Element:		ReceptorPositivityPercentage
		Concept:		TBD
		Description:	"The percentage of cells that test (stain) positive for the presence of a receptor."
		Value:			Percentage
		
		Element:		ReceptorProportionScore
		Concept:		TBD
		Description:	"Part of Allred scoring, based on the percentage of cells that stain for a receptor, on a scale of 0 to 5."
		Value:			unsignedInt  // limit to maximum value of 5

		Element:		ReceptorIntensityScore
		Concept:		TBD
		Description:	"Part of the Allred scoring, based on the intensity of that staining, on a scale of 0 to 3."
		Value:			unsignedInt  // limit to max of 3
		
		Element:		ReceptorTotalScore
		Concept:		TBD
		Description:	"Part of the Allred scoring, the total of proportion and intensity scores, from 0 to 8."
		Value:			unsignedInt // limit to max of 8

			
EntryElement:	BreastCancerReceptorStatus
Based on:		Panel
Concept:		TBD
Description:	"Immunohistochemistry (IHC) assessment for estrogen receptor (ER) and progesterone receptor (PR) as well as IHC or in situ hybridization (ISH) determination of human epidermal growth factor receptor 2 (HER2) status"
				PanelCode is TBD#TBD
1..1			EstrogenReceptorStatus
1..1			ProgesteroneReceptorStatus
1..1			HumanEpiduralGrowthFactorReceptor2Status
			
			EntryElement:	EstrogenReceptorStatus
			Based on:		ReceptorStatusObservation
			Concept:		TBD
			Description:	"Estrogen receptor alpha is the predominant estrogen receptor expressed in breast tissue and is overexpressed in around 50% of breast carcinomas. ER status (positive=present or overexpressed; negative=absent) is a factor in determining prognosis and treatment options."
							ObservationCode is TBD#TBD
							Receptor is SCT#23307004

			EntryElement:	ProgesteroneReceptorStatus
			Based on:		ReceptorStatusObservation
			Concept:		TBD
			Description:	"Progesterone receptor is expressed in 65% of breast carcinomas.13 PR status (positive=present or overexpressed; negative=absent) is a factor in determining prognosis and treatment options."
							ObservationCode is TBD#TBD
							Receptor is SCT#61078009
			
			EntryElement:	HumanEpiduralGrowthFactorReceptor2Status
			Based on:		ReceptorStatusObservation
			Concept:		MTH#C3810543
			Description:	"HER2 is a member of the human epidermal growth factor receptor family of proteins and is encoded by the ERBB2 oncogene. HER2 is overexpressed in 20-30% of breast tumors,10 and is associated with an aggressive clinical course and poor prognosis. HER2 status (positive=present or overexpressed; negative=absent) is a factor in determining prognosis and treatment options."
							ObservationCode is MTH#C3810543
							Receptor is TBD#TBD

EntryElement: 	TumorMeasurements
Description:	"Measurements and assessment of tumor, in situ via imaging, or of removed tumor. See CDISC Table 3.3.2"
Concept:		MTH#C4086369
Based on:		Panel
				PanelCode is MTH#C4086369
//0..1			TumorID
1..1			TumorPrimaryDimensionSize
0..1			TumorSecondaryDimensionSize
0..1			SizeOfGrossTumorBed
0..1			TumorMargins
0..1			Cellularity
0..1			PercentageInSituCarcinoma

		EntryElement:	TumorPrimaryDimensionSize
		Description:	"The longest diameter of the primary tumor."
		Based on:		QuantitativeObservation
		Value:			Quantity with units UCUM#mm

		EntryElement:	TumorSecondaryDimensionSize
		Description:	"The longest perpendicular diameter of the primary tumor."
		Based on:		QuantitativeObservation
		Value:			Quantity with units UCUM#mm
		
		EntryElement:	SizeOfGrossTumorBed
		Description:	"The largest dimension of the gross tumor bed/fibrotic area."
		Concept:		TBD#TBD
		Based on:		QuantitativeObservation
		Value:			Quantity with units UCUM#mm
		
		Element: 		TumorMargins
		Concept:		MTH#C1269830
		Description:	"The edge or border of the tissue removed in cancer surgery. The margin is described as negative or clean when the pathologist finds no cancer cells at the edge of the tissue, suggesting that all of the cancer has been removed. The margin is described as positive or involved when the pathologist finds cancer cells at the edge of the tissue, suggesting that all of the cancer has not been removed."
		Based on:		CodeableConceptObservation
		Value:			CodeableConcept from PositiveNegativeVS
		
		Element:		Cellularity
		Concept:		MTH#C4055283
		Description:	"The percentage of cells in a sample that are cancerous"
		Based on:		QuantitativeObservation
		// Value:			Percentage  
		
		Element:		PercentageInSituCarcinoma
		Concept:		TBD
		Based on:		QuantitativeObservation
		Description:	"The percentage of the cancer that is in situ, as opposed to invading other tissues."
		// Value:			Percentage 
		
		Element:		LargestLymphNodeSize
		Description:	""
		Concept:		MTH#C1285847
		Based on:		QuantitativeObservation
		Value: 			Quantity with units UCUM#mm

/*
FHIR Genomics:
https://www.hl7.org/FHIR/2016Jan/obs-genetics-example3-bcr1%20and%20bcr2%20sequencing%20with%20FamilyHistory%20-1.json.html
https://www.hl7.org/FHIR/2016Jan/observation-genetics-cg-prf-1a.html
https://www.hl7.org/FHIR/2016Jan/observation-genetics.html
https://www.hl7.org/FHIR/2016Jan/obs-genetics-example2-germline.html
		
		
Element:	BRCA1Mutation
Value:		CodeableConcept from PositiveNegativeVS

Element:	BRCA2Mutation
Value:		CodeableConcept from PositiveNegativeVS




		Element:	Biomarkers
		Based on:	Panel
					PanelCode is TBD#TBD
		
			EntryElement: 	Ki-67LabelingIndex
			Description:	"Ki-67 is a protein phosphatase whose expression is strongly associated with cell proliferation and encoded by the MKI67 gene. The Ki67 labeling index is the fraction of Ki-67-positive cells to total cells in a tumor specimen and may be useful for determining prognosis with respect to survival and disease recurrence. The more positive cells there are, the more quickly they are dividing and forming new cells. "
			Value:		Percentage
			ReferenceRange: Low <10, Intermediate 10-20, >20 High
			
			EntryElement:	S-PhaseFraction
			Description: "The S-phase fraction number tells you what percentage of cells in the tissue sample are in the process of copying their genetic information (DNA). This S-phase, short for synthesis phase, happens just before a cell divides into two new cells."	
			Value:		Percentage
			ReferenceRange: Low <6, Intermediate 6-10, >10 High
			
			EntryElement:	LuminalA
			
			EntryElement:	LuminalB
			
		Element:	NottinghamGrade

		Element:	HistologicType
		
		Element:	MicroscopicAppearance (poorly differentiated or well differentiated)


		


*/